Most lipolytic injections focus on fat reduction alone, which can leave skin laxity once volume is lost. Prime is built around a lecithin and vitamin B12 lipolytic base but adds growth factors (EGF, FGF), a peptide complex and antioxidants such as glutathione. The goal is to reduce fat while simultaneously supporting collagen, elastin and skin firmness in the same treated area.

When subcutaneous fat is reduced, the overlying skin can lose support and appear loose or wrinkled. EGF and FGF are growth factors associated with cellular regeneration, while peptides such as acetyl hexapeptide-8, palmitoyl pentapeptide-4 and palmitoyl tetrapeptide-7 are linked to collagen and elastin synthesis. Together they are intended to help the skin recover firmness as fat is reduced.

Yes. Prime is formulated for both facial and body contouring. On the face it is used around the chin and zygomatic (cheek) zone; on the body it targets areas such as the abdomen, waist, hips and thighs. The 2ml vial size is well suited to the more precise volumes typically used in facial work as well as smaller body zones.

Prime includes glutathione, ascorbic acid (vitamin C) and arbutin. These are recognized antioxidant and skin-tone ingredients that complement the firming actives by supporting overall skin quality, helping maintain elasticity and an even tone in the treated area.

Prime is for administration by licensed medical and aesthetic professionals only, by subcutaneous injection. It should be avoided in pregnancy and breastfeeding, in anyone with known allergy to its ingredients, and at sites with active infection. Patient suitability and screening must be assessed by the treating professional before any treatment.